Page last updated: 2024-09-03

umifenovir and Pulmonary Disease, Chronic Obstructive

umifenovir has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aleksandrov, AL; Kovaleva, LF; Kozyrev, AG; Kulikov, VD; Kuzubova, NA; Petrova, MA; Shklyarevich, NA; Titova, ON	1

Other Studies

1 other study(ies) available for umifenovir and Pulmonary Disease, Chronic Obstructive

Article	Year
Efficacy of Arbidol in the prevention of virus-induced exacerbations of bronchial asthma and chronic obstructive pulmonary disease. Terapevticheskii arkhiv, 2018, Aug-27, Volume: 90, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Asthma; Disease Progression; Humans; Indoles; Influenza, Human; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Young Adult	2018

Article

Year

Efficacy of Arbidol in the prevention of virus-induced exacerbations of bronchial asthma and chronic obstructive pulmonary disease.

Terapevticheskii arkhiv, 2018, Aug-27, Volume: 90, Issue:8

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Asthma; Disease Progression; Humans; Indoles; Influenza, Human; Middle Aged; Prospective Studies; Pulmonary Disease, Chronic Obstructive; Respiratory Tract Infections; Young Adult

2018